A Prospective Phase III Randomized Trial of Hypofractionation Versus Conventional Fractionation in Patients With High-Risk Prostate Cancer-Reference-Cited by-同舟云学术

A Prospective Phase III Randomized Trial of Hypofractionation Versus Conventional Fractionation in Patients With High-Risk Prostate Cancer

Published:2010-09 Issue:1 Volume:78 Page:11-18
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Arcangeli Giorgio,Saracino Biancamaria,Gomellini Sara,Petrongari Maria Grazia,Arcangeli Stefano,Sentinelli Steno,Marzi Simona,Landoni Valeria,Fowler Jack,Strigari Lidia

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference23 articles.

1. Prostate cancer radiation dose response: Results of the M.D. Anderson Phase III randomized trial;Pollack;Int J Radiat Oncol Biol Phys,2002

2. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized Phase III trial comparing 68 Gy of radiotherapy with 78 Gy;Peeters;J Clin Oncol,2006

3. Is alpha/beta for prostate tumors really low?;Fowler;Int J Radiat Oncol Biol Phys,2001

4. Direct evidence that prostate tumors shows high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue;Brenner;Int J Radiat Oncol Biol Phys,2002

5. Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer;Williams;Int J Radiat Oncol Biol Phys,2007

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofractionated Dose Escalation Radiotherapy for High-risk Prostate Cancer: The Survival Analysis of the Prostate Cancer Study 5, a Groupe de Radio-oncologie Génito-urinaire du Quebec–led Phase 3 Trial;European Urology;2024-09

2. Escalade de dose en radiothérapie modérément hypofractionnée pour les cancers de la prostate localisés, ESHYPRO : résultats d’une série monocentrique rétrospective évaluant la toxicité et l’efficacité;Cancer/Radiothérapie;2024-08

3. Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial;International Journal of Radiation Oncology*Biology*Physics;2024-01

4. Timing of High-Dose Rate Brachytherapy with External Beam Radiotherapy in intermediate and high-risk localised Prostate Cancer (THEPCA): a randomised trial;International Journal of Radiation Oncology*Biology*Physics;2023-12

5. Optimal Fractionation in Radiotherapy;2023-09-30